Lixoft Overview
- Status
-
Acquired/Merged
- Employees
-
20
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$18.6M
Lixoft General Information
Description
Developer of pharmacometrics modeling and simulation software intended to support drug development for pharmaceutical biotechnology and academic markets. The company provides services through its MonolixSuite platform, including population modeling, pharmacokinetic and pharmacodynamic analysis, clinical trial simulation, and data interpretation.
Contact Information
Website
www.lixoft.comCorporate Office
- 8 rue de la Renaissance
- Batiment D
- 92160 Antony
- France
Corporate Office
- 8 rue de la Renaissance
- Batiment D
- 92160 Antony
- France
Lixoft Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Merger/Acquisition | 01-Apr-2020 | $18.6M | Completed | Generating Revenue | ||
| 1. Accelerator/Incubator | 01-Jan-2010 | Completed | Startup |
Lixoft Comparisons
Industry
Financing
Details
Lixoft Competitors (3)
One of Lixoft’s 3 competitors is Schrodinger, a Formerly VC-backed company based in New York, NY.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Schrodinger | Formerly VC-backed | New York, NY | ||||
| Cytel | Private Equity-Backed | Cambridge, MA | ||||
| Acellera | Corporation | Barcelona, Spain |
Lixoft Patents
Lixoft Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-3222747-A1 | Method for determining an effect of a drug on a patient with a specific dose regimen | Pending | 11-Jun-2021 | ||
| EP-4102511-A1 | Method for determining an effect of a drug on a patient with a specific dose regimen | Inactive | 11-Jun-2021 | ||
| US-20240274253-A1 | Method for determining an effect of a drug on a patient with a specific dose regimen | Pending | 11-Jun-2021 | ||
| WO-2022258669-A1 | Method for determining an effect of a drug on a patient with a specific dose regimen | Inactive | 11-Jun-2021 | ||
| FR-2967512-A1 | Longitudinal data analysis method, computer program and corresponding system | Pending | 17-Nov-2010 | G06F17/18 |
Lixoft Signals
Lixoft Former Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| IncubAlliance | Accelerator/Incubator | Minority |
Lixoft FAQs
-
Where is Lixoft headquartered?
Lixoft is headquartered in Antony, France.
-
What is the size of Lixoft?
Lixoft has 20 total employees.
-
What industry is Lixoft in?
Lixoft’s primary industry is Business/Productivity Software.
-
Is Lixoft a private or public company?
Lixoft is a Private company.
-
What is the current valuation of Lixoft?
The current valuation of Lixoft is .
-
What is Lixoft’s current revenue?
The current revenue for Lixoft is .
-
Who are Lixoft’s investors?
IncubAlliance has invested in Lixoft.
-
Who are Lixoft’s competitors?
Schrodinger, Cytel, and Acellera are competitors of Lixoft.
-
When was Lixoft acquired?
Lixoft was acquired on 01-Apr-2020.
-
Who acquired Lixoft?
Lixoft was acquired by Simulations Plus.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process